Table 2.
Patient Characteristics: Earlier Group versus Later Group
| Characteristics | Earlier (2008–2016) (n=50) |
Later (2017–2020) (n=51) |
p-value |
|---|---|---|---|
| Age, yr | 77 (40–94) | 76 (43–96) | 0.301 |
| Sex, M/F | 33/17 | 31/20 | 0.586 |
| Cholecystitis | 0.561 | ||
| Mild | 31 (62.0) | 32 (62.7) | |
| Moderate | 12 (24.0) | 15 (29.4) | |
| Severe | 7 (14.0) | 4 (7.8) | |
| WBC, ×103/µL | 11.1±5.39 | 12.2±5.37 | 0.202 |
| CRP, mg/dL | 12.6±8.72 | 10.7±6.73 | 0.337 |
| GB stone | 38 (74.0) | 38 (74.5) | 0.862 |
| Background to challenge ETGBD | |||
| Comorbidity with CBD stone | 32 (64.0) | 26 (51.0) | 0.186 |
| Antithrombotic agents | 9 (18.0) | 11 (21.6) | 0.653 |
| Comorbidity with suspected GB cancer | 9 (18.0) | 4 (7.8) | 0.128 |
| Dementia | 10 (20.0) | 10 (19.6) | 0.961 |
| Ascites | 7 (14.0) | 5 (9.8) | 0.515 |
| Papilla | 0.339 | ||
| Naïve | 34 (68.0) | 30 (58.8) | |
| Post-EST | 16 (32.0) | 21 (41.2) |
Data are presented as median (range), number (%), or mean±SD.
M, male; F, female; WBC, white blood cell; CRP, C-reactive protein; GB, gallbladder; ETGBD, endoscopic transpapillary gallbladder drainage; CBD, common bile duct; EST, endoscopic sphincterotomy.